ecancermedicalscience

Research

Net survival for colorectal cancer in Cuiabá and Várzea Grande (state of Mato Grosso), Brazil

2 Mar 2021
Christiane Maria Meurer Alves, Pedro Cainelli de Oliveira Prado, Ronaldo Rocha Bastos

In studies of cancer survival, Population-Based Cancer Registries (PBCRs) can provide an overview of the disease for places that have this source of information available. In Brazil, PBCR is officially available in 22 state capitals and 8 cities in the interior of the country. PBCR data from Cuiabá and Várzea Grande, state of Mato Grosso, in Midwestern Brazil, were used to estimate the survival rate of colon (C18), rectosigmoid junction (C19) and rectum (C20) cancer cases diagnosed in 2000–2009 according to the International Classification of Diseases, 10th Revision. Five-year survival rate was estimated by the unbiased and consistent net survival estimator, which is used in the country estimates of the global surveillance of cancer survival programme CONCORD Group, for all cases, and also by sex, age group, diagnosis period and place of residence. The probability of death and the number of years of life lost to illness were also estimated. The estimated standardised 5-year survival rate for colorectal cancer was 45.46% (95% CI: 43.09%–47.96%) in the cities of Cuiabá and Várzea Grande. There was no difference between the curves when the survival rate was assessed by diagnostic period (2000–2004 and 2005–2009), sex, age group or city of residence. The gross 5-year probability of death from the disease was 51.2%, accounting for 6.4% of the gross probability of death from other causes, with 2.07 being the years of life lost to illness. The results obtained for Cuiabá and Várzea Grande are compatible with survival rates estimated for Brazil in the CONCORD study, but demonstrate the need to identify reasons why we continue to have low survival rates when compared to most countries involved in the global study mentioned. The results may reflect late diagnosis, difficult access and delays in starting treatment.

Related Articles

Divya Bala Thumaty, Titus Chacko Raju, Oommen John Ajoy, Anjana Joel, Josh Thomas Georgy, Myla Jacob, Inian Samarasam, Dipti Masih, Rajesh Isaiah, Visalakshi Jeyaseelan, Ashish Singh
Shridevi Subramaniam, Yek-Ching Kong, Hafizah Zaharah, Cuno SPM Uiterwaal, Andrea Richard, Nur Aishah Taib, Azura Deniel, Kok-Han Chee, Ros Suzanna Bustamam, Mee-Hoong See, Alan Fong, Cheng-Har Yip, Nirmala Bhoo-Pathy
Tapesh Bhattacharyya, Moses Arunsingh, Santam Chakraborty, Vishnu Harilal, Rohit Sasidharan, Saheli Saha, Robin Thambudorai, Bipradas Roy, Sudeep Banerjee, Paromita Roy, Soumendranath Ray, Indranil Mallick
Jeel Moya-Salazar, Eulogio Cáceres, Jorgelina Blejer, Carlos Gonzalez, Hans Contreras-Pulache
Sare Hatamian, Fatemeh Hadavandsiri, Zohre Momenimovahed, Hamid Salehiniya
Jéssica Silva Nicolau, Rossana Veronica Mendoza Lopez, Carolina Terra de Moraes Luizaga, Karina Braga Ribeiro, Rosimeire Aparecida Roela, Simone Maistro, Maria Lucia Hirata Katayama, Renato José Mendonça Natalino, Gilberto de Castro Jr, Jose Eluf Neto, Maria Aparecida Azevedo Koike Folgueira